FDA 'slow-walking' Novavax authorization: Expert

What began as branding and fandom at the start of the rollout of COVID-19 vaccines last year continues despite the slowdown in vaccine uptake. Increasing support for still unauthorized COVID-19 vaccines in the U.S. is growing, even as restrictions are waning amid the ongoing pandemic.